Patents by Inventor Wen Zhang

Wen Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150056858
    Abstract: A receptacle connector (100) includes an insulative housing (1), a number of contacts (2) retained in the insulative housing, a metal shield (3) covering the insulative housing, a metal plate (4) assembled to the metal shield along a vertical direction perpendicular to the mating direction, and an insulative cover (5) fully molded over the metal shield and partly molded over the metal plate. The metal plate defines a pair of closed slits (412) behind a rear face of the insulative housing. The insulative cover terminates at the closed slits in a mating direction along which a mating plug connector is inserted.
    Type: Application
    Filed: August 21, 2014
    Publication date: February 26, 2015
    Inventors: JING-JIE GUO, WEN-ZHANG LIN
  • Patent number: 8962566
    Abstract: Among other aspects, provided herein are multi-armed polymer conjugates comprising an alkanoate-linker, compositions comprising such conjugates, and related methods of making and administering the same. Methods of treatment employing such conjugates and related uses are also provided. The conjugates are prepared with high drug loading efficiencies.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: February 24, 2015
    Assignee: Nektar Therapeutics
    Inventors: Antoni Kozlowski, Samuel P. McManus, Jennifer Riggs-Sauthier, Xiaoming Shen, Wen Zhang
  • Patent number: 8937180
    Abstract: Provided herein is a straightforward and efficient method for covalently attaching a polyethylene glycol polymer to a taxane. The method involves, among other things, a step of reacting a taxane with a polyethylene glycol polymer comprising a functional group reactive with a functional group within said taxane in the presence of a coupling reagent and DPTS. The result of the reacting step is the formation of a polyethylene glycol-taxane conjugate.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: January 20, 2015
    Assignee: Nektar Therapeutics
    Inventor: Wen Zhang
  • Publication number: 20150009939
    Abstract: The present invention discloses a method for indicating resource assignment, comprising: obtaining, by a network side device, the number N0 of a resource block RB that the network side device can assign to one UE and the one UE can schedule in maximum; calculating, by the network side device, a resource indication value RIV according to the number N0 of the RB the network side device can assign to the UE and the UE can schedule in maximum and the number NRB of resource blocks corresponding to a bandwidth the network side device can assign to all UEs for use; and sending the calculated resource indication value RIV to the one user equipment. In contrast to the prior art, it may save the number of bits used by the resource indication and lower signaling cost.
    Type: Application
    Filed: September 19, 2014
    Publication date: January 8, 2015
    Inventors: Wen ZHANG, Yongxia LV
  • Publication number: 20150004500
    Abstract: According to one embodiment, there is provided an electrode material. The electrode material includes an active material which includes a titanium oxide compound having a monoclinic titanium dioxide crystal structure. The electrode material further includes a compound which exists on the surface of the active material and has a trialkylsilyl group represented by the formula (I). wherein R1, R2 and R3, which may be the same or different, respectively represent an alkyl group having 1 to 10 carbon atoms.
    Type: Application
    Filed: September 15, 2014
    Publication date: January 1, 2015
    Applicant: Kabushiki Kaisha Toshiba
    Inventors: Keigo Hoshina, Wen Zhang, Yasuhiro Harada, Hiroki Inagaki, Norio Takami
  • Patent number: 8921371
    Abstract: The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water-soluble, non-peptidic oligomer.
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: December 30, 2014
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Wen Zhang
  • Publication number: 20140362813
    Abstract: The present invention discloses a method and a device for resource configuration, the method includes: at first a base station broadcasts public resource configuration to a user equipment on a broadcast channel, and then the base station obtains an available public resource after receiving public resource requesting information sent by a target user equipment in a desynchronization state, the target user equipment is a user equipment of the user equipments which is in a desynchronization state; finally the base station sends an index number of the available public resource to the target user equipment, so that the target user equipment performs data transmission through the available public resource corresponding to the index number of the available public resource. The present invention can be applied to the field of communication system.
    Type: Application
    Filed: August 25, 2014
    Publication date: December 11, 2014
    Inventors: Zhenxing HU, Yongqiang GAO, Wen ZHANG, Yue LI
  • Publication number: 20140348089
    Abstract: Embodiments of the present invention provide a data sending method. The data sending method includes: determining, according to location generation information of a PDCCH on a non-legacy resource, a resource location, on a subframe, of the PDCCH on the non-legacy resource; and sending the subframe to a UE, where the PDCCH on the non-legacy resource is contained on the resource location of the subframe, so that the UE determines the resource location, on the subframe, of the PDCCH on the non-legacy resource according to the location generation information. In the embodiments of the present invention, both the base station and the UE may determine a resource location of the PDCCH on the non-legacy resource separately by using the location generation information, thereby avoiding a circumstance that the UE equipped with only the capability of receiving a PDCCH on a non-legacy resource cannot access a network.
    Type: Application
    Filed: July 21, 2014
    Publication date: November 27, 2014
    Inventors: Yongxia LV, Wen ZHANG, Yue LI
  • Patent number: 8895188
    Abstract: According to one embodiment, there is provided an electrode material. The electrode material includes an active material which includes a titanium oxide compound having a monoclinic titanium dioxide crystal structure. The electrode material further includes a compound which exists on the surface of the active material and has a trialkylsilyl group represented by the formula (I). wherein R1, R2 and R3, which may be the same or different, respectively represent an alkyl group having 1 to 10 carbon atoms.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: November 25, 2014
    Assignee: Kabushiki Kaisha Toshiba
    Inventors: Keigo Hoshina, Wen Zhang, Yasuhiro Harada, Hiroki Inagaki, Norio Takami
  • Publication number: 20140329828
    Abstract: The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water-soluble, non-peptidic oligomer.
    Type: Application
    Filed: July 21, 2014
    Publication date: November 6, 2014
    Applicant: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Wen Zhang
  • Publication number: 20140329049
    Abstract: A thermally insulating member includes a plane sheet having two ends spaced in a length direction and two sides spaced in a thickness direction perpendicular to the length direction. The plane sheet includes a plurality of rows of slits between the ends of the plane sheet. Each row of slits extends from one of the sides through the other side of the plane sheet. A first spacing between two adjacent rows of slits in the length direction is larger than a spacing between two adjacent slits in the same row of slits in a width direction perpendicular to the length and width directions by a second spacing. A thermally insulating strip is defined between two adjacent rows of slits. A stretchable rib is formed between two adjacent slits in the same row of slits. Each end of the plane sheet is a coupling portion free of the slits.
    Type: Application
    Filed: April 29, 2014
    Publication date: November 6, 2014
    Applicant: LlAN YI DESIGN ENTERPRISE CO., LTD.
    Inventor: Shao-Wen Zhang
  • Publication number: 20140315421
    Abstract: A waterproof electrical connector (100) includes a number of terminals (2), a metallic shell (1), and an insulating housing (3) molded outside of the metal shell (1) to thereby define a passageway (10). The insulating housing (1) includes a base portion (33) and a tongue portion (31) extending forwardly from the base portion (33). The base portion (33) includes at least one mold cavity (331) for inserting a mold. The mold cavity (331) and the passageway (10) are spaced apart from each other along the insertion/extraction direction for having better waterproof function.
    Type: Application
    Filed: April 17, 2014
    Publication date: October 23, 2014
    Applicant: HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: CEN LU, JING-JIE GUO, WEN-ZHANG LIN
  • Publication number: 20140309398
    Abstract: The invention provides corticosteroids that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits different properties compared to the properties of the corticosteroid not attached to the water-soluble oligomer.
    Type: Application
    Filed: June 26, 2014
    Publication date: October 16, 2014
    Inventors: Wen Zhang, Jennifer Riggs-Sauthier, J. Milton Harris, Michael D. Bentley
  • Publication number: 20140296334
    Abstract: The invention relates to (among other things) N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides and compositions comprising the same. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Application
    Filed: October 14, 2011
    Publication date: October 2, 2014
    Inventors: Jennifer Riggs-Sauthier, Wen Zhang
  • Patent number: 8841419
    Abstract: Hybridoma cell line 10G4 and monoclonal antibody against total aflatoxins produced by the hybridoma cell line 10G4. The hybridoma cell line 10G4 is used to produce the monoclonal antibody that binds specifically total aflatoxin B1, B2, G1 and G2. The titer of the mouse ascites antibody produced by the 10G4 treated mouse is determined through non-competitive enzyme-linked immunosorbent assay and the titer can reach up to 5.12×105. The monoclonal antibody against total aflatoxin B1, B2, G1 and G2 are used for better identification of aflatoxin B1, B2, G1 and G2 with good consistency. The 50% inhibitory concentrations (IC50) of the antibody against aflatoxin B1, B2, G1 and G2 are 2.09 ng/mL, 2.23 ng/mL, 2.19 ng/mL and 3.21 ng/mL respectively. The range of cross reaction rate for aflatoxin B1, B2, G1 and G2 is about 65.2%-100%. The antibody is used for quantitative measurement of total aflatoxin B1, B2, G1 and G2.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: September 23, 2014
    Assignee: Oilcrops Research Institute of Chinese Academy of Agriculture Sciences
    Inventors: Peiwu Li, Xin Li, Qi Zhang, Xiaoxia Ding, Wen Zhang, Ran Li, Zhaowei Zhang
  • Publication number: 20140278490
    Abstract: A system and method for grouping medical codes for clinical predictive analytics is provided.
    Type: Application
    Filed: March 7, 2014
    Publication date: September 18, 2014
    Applicant: OPERA SOLUTIONS, LLC
    Inventors: Mahdi Namazifar, Wen Zhang, Yan Zhang
  • Publication number: 20140249161
    Abstract: Stilbene analogs and pharmaceutical compositions that are useful for the treatment of various cancers, including without limitation, colorectal cancer (CRC) and breast cancer are disclosed. The halogenated stilbene analogs include nitrogen heteroaryl groups and/or amino groups on the stilbene ring.
    Type: Application
    Filed: February 27, 2014
    Publication date: September 4, 2014
    Applicant: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: David WATT, Chunming LIU, Vitaliy M. SVIRIPA, Wen ZHANG
  • Patent number: 8816077
    Abstract: The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water soluble, non peptidic oligomer.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: August 26, 2014
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Wen Zhang
  • Patent number: 8796248
    Abstract: The invention provides corticosteroids that are chemically modified by covalent attachment of a water soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits a reduced biological membrane crossing rate as compared to the biological membrane crossing rate of the corticosteroid not attached to the water soluble oligomer.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: August 5, 2014
    Assignee: Nektar Therapeutics
    Inventors: Wen Zhang, Jennifer Riggs-Sauthier, J. Milton Harris, Michael D. Bentley
  • Publication number: 20140188417
    Abstract: An electrical impedance detecting device of a portable electrical impedance imaging system by utilizing a theory of sending excitation signal and detecting response signal and a method thereof, wherein the excitation signal is a constant square wave excitation current signal, the response voltage signal on a target is transformed to a square wave signal with appropriate amplitudes by buffering, amplifying, RC filtering and differential amplifying circuits, and then is transformed to a digital signal at a proper time by an analog-to-digital converter. The response voltage signal is sampled once when at high level and once when at low level for every circle of the square wave signal by the ADC, and a sample V1 and a sample V2 are obtained respectively, difference of the sample V1 and the sample V2 is taken as a detecting result for one circle. An average value of the detecting result from a plurality of circles may be taken as a final result.
    Type: Application
    Filed: October 13, 2011
    Publication date: July 3, 2014
    Applicant: FOURTH MILITARY MEDICAL UNIVERSITY
    Inventors: Xiuzhen Dong, Xuyang Huo, Fusheng You, Xuetao Shi, Feng Fu, Ruigang Liu, Zhenyu Ji, Canhua Xu, Bin Yang, Min Yang, Jiaxue Qi, Wen Zhang, Nan Wang